Proqr Therapeutics
(PRQR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,146 | -8,314 | -30,018 | -24,219 | -18,354 |
| Depreciation Amortization | 1,510 | 750 | 2,720 | 1,943 | 1,246 |
| Other Working Capital | -14,902 | -10,015 | 52,985 | 50,785 | 53,068 |
| Other Operating Activity | 1,506 | 1,150 | -2,366 | 737 | 1,526 |
| Operating Cash Flow | $-23,033 | $-16,429 | $23,321 | $29,245 | $37,486 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -18,307 | -18,457 | N/A | N/A | N/A |
| PPE Investments | -1,076 | -795 | -1,419 | -786 | -418 |
| Purchase Sale Intangibles | N/A | N/A | 8,594 | N/A | N/A |
| Other Investing Activity | 0 | 0 | 6,049 | 0 | 0 |
| Investing Cash Flow | $-19,383 | $-19,252 | $4,630 | $-786 | $-418 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | -1,091 | N/A | N/A |
| Common Stock Issued | 187 | 176 | 383 | 169 | 4 |
| Other Financing Activity | -942 | -631 | -1,754 | -1,456 | -988 |
| Financing Cash Flow | $-755 | $-455 | $-2,462 | $-1,288 | $-984 |
| Exchange Rate Effect | 143 | 77 | 648 | 884 | 757 |
| Beginning Cash Position | 128,070 | 129,117 | 102,575 | 103,153 | 103,343 |
| End Cash Position | 85,043 | 93,059 | 128,713 | 131,209 | 140,184 |
| Net Cash Flow | $-43,028 | $-36,058 | $26,138 | $28,056 | $36,841 |
| Free Cash Flow | |||||
| Operating Cash Flow | -23,033 | -16,429 | 23,321 | 29,245 | 37,486 |
| Capital Expenditure | -1,076 | -795 | -1,484 | -837 | -469 |
| Free Cash Flow | -24,109 | -17,224 | 21,838 | 28,408 | 37,017 |